Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/2003
11/05/2003CN1126551C Chinese herb medicine for treating coronary heart disease
11/05/2003CN1126454C Control of enterohemorrhagic E Coli 0157:H7 of cattle with probiotic bacteria
11/04/2003US6642369 Nucleic acids involved in the responder phenotype and applications thereof
11/04/2003US6642363 Bonded to a peptide which promotes cell adhesion and growth; use in drug delivery, cell transplantation and tissue engineering
11/04/2003US6642359 Peptide or protein for use in the diagnosis, treatment or prophylaxis of viral disease
11/04/2003US6642207 Artificial chromosome constructs containing foreign nucleic acid sequences
11/04/2003US6642202 Egg having active oxygen eliminating ability and method of producing same
11/04/2003US6642049 Human brain endothelial cells and growth medium and method for expansion of primitive CD34+CD38-bone marrow stem cells
11/04/2003US6642048 Conditioned media for propagating human pluripotent stem cells
11/04/2003US6641849 Mixture of L-carnitine, acetyl L-carnitine, and propionyl L-carnitine or salts; cardiovascular, gastrointestinal, sleep, nervous system, and nervous system disorders
11/04/2003US6641837 Flavored vegetable starch capsule
11/04/2003US6641820 Treating a bone tumor, in particular pain associated with bone tumor, by administration to a patient of a therapeutically effective amount of an agent are disclosed. The agent may include a clostridial neurotoxin component attached to target
11/04/2003US6641817 Herpes virus vectors for dendritic cells
11/04/2003US6641816 Use of poxviruses as enhancer of specific immunity
11/04/2003US6641808 Composition for treatment of obesity
11/04/2003US6641807 Helper dependent adenoviral vectors encoding erythropoietin provide high levels of epo to achieve a long-term therapeutically effective dosage, and allow for repeat administration to patients with disorders such as anaemia of
11/04/2003US6641526 Development of normal offspring from oocytes injected with freeze-dried spermatozoa
10/2003
10/30/2003WO2003089631A1 Method for propagating stem cells and/or progenitor cells
10/30/2003WO2003089619A2 Placental derived stem cells and uses thereof
10/30/2003WO2003089596A2 Novel prostate tumor-specific promoter
10/30/2003WO2003089592A2 Enhancement of hematopoietic stem cell survival
10/30/2003WO2003088984A1 Compositions and methods for augmenting kidney function
10/30/2003WO2003088935A1 Compositions and methods for inducing new hair follicle formation and hair growth in a desired orientation
10/30/2003WO2003088905A2 Compositions and minimally invasive methods for treating incomplete tissue repair
10/30/2003WO2003088763A1 Methods for producing low cholesterol animal products using hypocholesterolemic feed supplements and products therefrom
10/30/2003WO2003055989A3 Cellular compositions and methods of making and using them
10/30/2003WO2003053365A3 Syn3 compositions and methods
10/30/2003WO2003051831A3 Protease inhibitors of the coagulation cascade isolated from dysidea sponges
10/30/2003WO2003051378A3 Pharmaceutical composition for topical treatment of skin disorders and skin wounds
10/30/2003WO2003049552A3 Beverage treated with nicotine
10/30/2003WO2003039481A3 Adipose tissue-derived stromal cells for the repair of corneal and intra-orbital defects and uses thereof
10/30/2003WO2003031588A3 Hepatitis c virus vaccine
10/30/2003WO2003018821A3 Compositions and methods for treating neurodegenerative diseases
10/30/2003WO2003014305A3 Eukaryotic cells and method for preserving cells
10/30/2003WO2003004661A3 Adenovital vectors with cell type specificity for mesenchymal cells
10/30/2003WO2002090526A3 Human secreted proteins
10/30/2003WO2002074330A3 Mycobacterrial estracts for treating autoimmune diseases
10/30/2003WO2002060276A8 Combination of probiotics
10/30/2003WO2002050243A3 The use of ecm degrading enzymes for the improvement of cell transplantation
10/30/2003WO2002018583A9 Modified polypeptides stabilized in a desired conformation and methods for producing same
10/30/2003WO2002007742A8 Bacteriophage having multiple host range
10/30/2003US20030204069 Segments of the human gene for telomerase reverse transcriptase
10/30/2003US20030204060 Prepared by fermenting, incubating and eluting by washing with buffer, then chromatographing concentrated medium with lipophilic immobile phase comprising carrier coupled to 2-mercapto/hydroxyalkanoic acid
10/30/2003US20030203863 Interleukins (IL-2); cytokines; bovine growth hormone; cytomegalovirus; gene therapy
10/30/2003US20030203850 Transdifferentiation of pancreatic acinar cells
10/30/2003US20030203488 Plasmid comprising components from herpesvirus, cytomegalovirus, adeno-associated virus, poxvirus and adenovirus which permits the transfer and expression of genes of interest in preferential cells
10/30/2003US20030203484 Inducing differentiation of isolated marrow stromal cell into a neuronal cell using neuronal differentiation-inducing compound such as dimethylsulfoxide and butylated hydroxyanisole for treating nervous system disorders
10/30/2003US20030203483 Differentiated mesenchymal cells for enhancing engraftment of hematopoietic progenitor cells, bone marrow transplantation or treatment and/or prevention of graft versus host disease
10/30/2003US20030203057 A mixture of isoflavones or isoflavone glycosides, pungent, bitter and sour substances and/or scymnol and scymnol esters; secretion of biogenic monoamines; antidepressants; seasonal affective disorder; Alzheimer's disease and much more!
10/30/2003US20030203047 Composition and method for increasing testosterone levels
10/30/2003US20030203043 Composition and method for increasing testosterone levels
10/30/2003US20030203041 Fungus inhibiting biological compound
10/30/2003US20030202991 Delivery of biologically active polypeptides
10/30/2003US20030202979 Mixture of lecithin and polymer
10/30/2003US20030202966 Isolated stromal cells and methods of using the same
10/30/2003US20030202965 Vitiligo therapy; tissue engineering
10/30/2003US20030202960 Therapeutic angiogenic factors and methods for their use
10/30/2003US20030201160 Sterilization, neutralization of infectous viruses in blood; removal adenine, exposure to photosentizer
10/30/2003CA2642653A1 Blood component processing system, apparatus and method
10/30/2003CA2642652A1 Blood component processing system, apparatus and method
10/30/2003CA2483010A1 Placental derived stem cells and uses thereof
10/30/2003CA2481406A1 Enhancement of hematopoietic stem cell survival
10/30/2003CA2481104A1 Compositions and methods for inducing new hair follicle formation and hair growth in a desired orientation
10/30/2003CA2478991A1 Compositions and methods for augmenting kidney function
10/29/2003EP1356733A2 Pesticidal and antiparasitic compositions
10/29/2003EP1356277A2 Method for altering cell fate
10/29/2003EP1356092A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/29/2003EP1356071A2 Genetically engineered herpes virus for the treatment of cardiovascular disease
10/29/2003EP1356070A2 Conditionally replicating viral vectors and their use
10/29/2003EP1356024A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
10/29/2003EP1355925A2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
10/29/2003EP1355659A2 Use of compositions containing pdgf-bb for promoting angiogenesis
10/29/2003EP1355656A2 Red blood cell as vehicle for agent-membrane translocation sequence conjugate
10/29/2003EP1355653A2 Stimulation of thymus for vaccination development
10/29/2003EP1355566A2 Local regional chemotherapy and radiotherapy using in situ hydrogel
10/29/2003EP1355563A2 METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES
10/29/2003EP1355542A2 Nutritional composition with health promoting action containing oligosaccharides
10/29/2003EP1355541A1 Alpha-lactalbumin as prebiotic agent
10/29/2003EP1082129B1 Method for the treatment of fertility disorders
10/29/2003EP1032265B1 New psoralens for pathogen inactivation
10/29/2003EP0920322B9 Use of modified autologous blood for the treatment of autoimmune diseases
10/29/2003EP0444186B2 Pharmaceutical composition that makes cells expressing mhc class ii antigens targets for cytotoxic t-cells
10/29/2003CN1452496A Use of strains of parapox ovis virus against organ fibrosis
10/29/2003CN1451432A Medicine for treating neck, shoulder, waist and leg pains
10/29/2003CN1451430A Medicine composition for treating ischemic necrosis of femur head and preparing process thereof
10/29/2003CN1451425A Medicine for treating chronic gastritis and preparing process thereof
10/29/2003CN1451402A Chinese medicinal preparation for treating cadiovascular and cerebrovascular diseases
10/29/2003CN1451395A Use of silkworm excrement extract for treating iron-deficiency anemia
10/29/2003CN1451394A Superfine pearl powder and producing process thereof
10/29/2003CN1451393A Clam extract, and preparing process and use thereof
10/29/2003CN1125647C Fumigation washing matter for treating anal diseases
10/29/2003CN1125646C Solid beverage for prevention and control of essential hypertension and productive method thereof
10/29/2003CN1125645C Ointment for treating psoriasis
10/29/2003CN1125644C Ointment for treating acne
10/29/2003CN1125643C External use medicine for treating psoriasis
10/29/2003CN1125642C Pharmaceuticals for treating gastroducdenal ulcer and gastritis and its prepn. process
10/29/2003CN1125641C Hongkong foot treating ointment
10/28/2003US6638913 Concentrated injection and infusion solution for intravenous administration
10/28/2003US6638910 Compositions and methods for controlling plant pests
10/28/2003US6638765 Platform for the differentiation of cells